Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
22
MTNB Quote, Financials, Valuation and Earnings
Last price:
$0.54
Seasonality move
:
13.52%
Day range:
$0.53 - $0.57
52-week range:
$0.50 - $21.50
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.60x
P/B ratio:
0.18x
Volume:
63.4K
Avg. volume:
284K
1-year change:
-95.05%
Market cap:
$2.8M
Revenue:
$1.1M
EPS (TTM):
-$4.79
Earnings Data
Next earnings date for MTNB
Mar 27
2025
Most recent earnings per share
-$0.85
Beat by $0.21
(Nov 13/2024)
Consensus Estimate
-$1.06
(Nov 13/2024)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
MTNB Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/27/2025 | Q4 | -- | -- | -- | -$0.78 | -- |
| 11/13/2024 | Q3 | -- | -- | -$0.85 | -$1.06 | $0.21 |
| 08/14/2024 | Q2 | -- | -- | -$1.00 | -$1.00 | -- |
| 05/09/2024 | Q1 | -- | -- | -$1.50 | -$1.50 | -- |
| 03/27/2024 | Q4 | -- | -- | -$1.44 | -$1.50 | $0.06 |
| 11/08/2023 | Q3 | -- | -- | -$1.39 | -$1.50 | $0.11 |
| 08/09/2023 | Q2 | -- | -- | -$1.50 | -$1.50 | -- |
| 05/10/2023 | Q1 | $300K | $1.1M | -$1.50 | -$1.50 | -- |
| 03/15/2023 | Q4 | $721K | $1.1M | -$1.00 | -$1.25 | $0.25 |
| 11/02/2022 | Q3 | $846.5K | $1.1M | -$1.50 | -$1.50 | -- |
| 08/11/2022 | Q2 | -- | $1.1M | -$1.50 | -- | -- |
| 05/12/2022 | Q1 | -- | -- | -$1.50 | -- | -- |
| 03/08/2022 | Q4 | -- | -$330 | -$1.50 | -- | -- |
| 11/08/2021 | Q3 | -- | -- | -$1.50 | -- | -- |
| 08/10/2021 | Q2 | -- | -- | -$1.00 | -- | -- |
| 05/10/2021 | Q1 | -- | $33.3K | -$1.50 | -- | -- |
| 03/29/2021 | Q4 | -- | $62.5K | -$1.50 | -- | -- |
| 11/06/2020 | Q3 | -- | $95.8K | -$1.50 | -- | -- |
| 08/10/2020 | Q2 | -- | -- | -$1.50 | -- | -- |
| 05/11/2020 | Q1 | -- | -- | -$1.50 | -- | -- |
| 03/09/2020 | Q4 | -- | -- | -$2.00 | -- | -- |
| 11/13/2019 | Q3 | -- | -- | -$1.50 | -- | -- |
| 08/13/2019 | Q2 | -- | $89.8K | -$1.50 | -- | -- |
| 04/02/2019 | Q1 | -- | -- | -$2.00 | -- | -- |
| 12/31/2018 | Q4 | -- | -- | -$1.50 | -- | -- |
| 11/12/2018 | Q3 | -- | -- | -$1.50 | -- | -- |
| 08/10/2018 | Q2 | -- | $89.8K | -$2.00 | -- | -- |
| 05/10/2018 | Q1 | -- | $29.9K | -$2.50 | -- | -- |
| 03/19/2018 | Q4 | -- | $44.9K | -$2.00 | -- | -- |
| 11/15/2017 | Q3 | -- | $44.9K | -$2.00 | -- | -- |
| 08/08/2017 | Q2 | -- | $44.9K | -$2.00 | -- | -- |
| 03/31/2017 | Q1 | -- | $15K | -$12.50 | -- | -- |
| 12/31/2016 | Q4 | -- | -- | -$1.50 | -- | -- |
| 09/30/2016 | Q3 | -- | -- | -$5.50 | -- | -- |
| 06/30/2016 | Q2 | -- | -- | -$1.50 | -- | -- |
| 03/31/2016 | Q1 | -- | -- | -$2.00 | -- | -- |
| 12/31/2015 | Q4 | -- | -- | -$2.00 | -- | -- |
| 09/30/2015 | Q3 | -- | $59.9K | -$2.00 | -- | -- |
| 06/30/2015 | Q2 | -- | $77K | -$2.00 | -- | -- |
| 03/31/2015 | Q1 | -- | $57.6K | -$3.50 | -- | -- |
| 12/31/2014 | Q4 | -- | -- | -$5.00 | -- | -- |
Matinas BioPharma Holdings Earnings Questions
-
How Much did Matinas BioPharma Holdings Generate in Revenue Last Quarter?
Matinas BioPharma Holdings reported -- worth of top line sales in its most recent quarter.
-
Did Matinas BioPharma Holdings Beat Earnings Last Quarter?
Matinas BioPharma Holdings announced earnings per share of -$0.85 which represents a beat of analyst forecast a -$1.06 per share.
-
Is Matinas BioPharma Holdings Profitable?
Matinas BioPharma Holdings reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Matinas BioPharma Holdings EPS Next Year?
Matinas BioPharma Holdings's earnings are forecast to decrease from -$5.50 per share to -$5.50 per share next year representing a decrease of -26.18%.
-
When is Matinas BioPharma Holdings's Earnings Date?
Matinas BioPharma Holdings's next earnings date is March 27, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
